Caleb Willis

Title: The Innovative Contributions of Caleb Willis

Introduction

Caleb Willis is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of histopathology. With a total of eight patents to his name, he has developed innovative methods that enhance the analysis of nucleic acids in tumor cells.

Latest Patents

One of his latest patents is focused on predicting total nucleic acid yield and dissection boundaries for histology slides. This method qualifies a specimen prepared on hematoxylin and eosin (H&E) slides by assessing the expected yield of nucleic acids for tumor cells and providing associated unstained slides for subsequent nucleic acid analysis. Another notable patent involves determining biomarkers from histopathology slide images. This system identifies biomarkers in a digital image of a Hematoxylin and Eosin-stained slide of target tissue. It includes a processor and an electronic network, along with a memory that stores computer-executable instructions. When executed, these instructions process segmented tile images to determine predicted biomarker presence and transmit the results.

Career Highlights

Caleb has worked with notable companies such as Tempus Labs, Inc. and Tempus AI, Inc. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology.

Collaborations

Caleb has collaborated with talented individuals in his field, including Stephen Yip and Irvin Ho. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in histopathology.

Conclusion

Caleb Willis stands out as an influential inventor whose work has significantly impacted the field of histopathology. His innovative patents and collaborations continue to pave the way for advancements in medical research and technology.